NIOX®

NIOX® is a pioneering company based in the UK, dedicated to advancing respiratory health through innovative diagnostic solutions. With a strong focus on asthma management, NIOX® develops and manufactures cutting-edge devices that measure fractional exhaled nitric oxide (FeNO), a biomarker for airway inflammation.

Founded with the vision of improving patient outcomes, NIOX® aims to empower healthcare professionals with precise tools for diagnosing and monitoring respiratory conditions. The company’s flagship product, the NIOX VERO®, is designed for ease of use, providing accurate results in real-time, which aids in the effective management of asthma.

NIOX® is committed to research and development, continuously striving to enhance its product offerings and expand its reach within the global healthcare market. The company collaborates with leading medical institutions and researchers to ensure that its technologies are at the forefront of respiratory care.

• Core Values: Innovation, Quality, and Patient-Centric Care
• Mission: To provide healthcare professionals with reliable diagnostic tools that improve asthma management.
• Vision: A world where respiratory diseases are effectively managed through advanced technology.

With a dedicated team of experts and a commitment to excellence, NIOX® is poised to make significant contributions to the field of respiratory health. The company’s headquarters is located in the heart of the UK, where it continues to grow and evolve in response to the needs of patients and healthcare providers alike.